News Conference News ACC 2013 Rosuvastatin Helps Stave Off Contrast Nephropathy in NSTE-ACS Patients L.A. McKeown March 09, 2013
News Conference News ACC 2013 Cangrelor Consistently Comes Out Ahead of Clopidogrel in All PCI Patients Yael L. Maxwell March 09, 2013
Presentation ACC 2013 A Post-market Study to Assess the STENTYS Self-exPanding COronary Stent In AcuTe myocardIal InfarctiON in Real Life: APPOSITION III Study Presenter: Gilles Montalescot March 08, 2013
News Conference News ACC 2013 DEFER-STEMI: Holding Off Stenting for Several Hours Improves Outcomes L.A. McKeown March 08, 2013
News Conference News ACC 2012 ACC-i2 Scientific Session 2012: Cooperation Key as Practice Changing Results Released Yael L. Maxwell April 02, 2012
News Conference News ACC 2012 Early Cardiac CTA Improves Decision-Making in Suspected ACS L.A. McKeown March 27, 2012
News Conference News ACC 2012 Benefits of Transradial PCI May be Limited to High Volume Centers Jason Kahn March 27, 2012
News Conference News ACC 2012 Daily Rivaroxaban as Effective as Enoxaparin for Pulmonary Embolism L.A. McKeown March 26, 2012
News Conference News ACC 2012 Coronary CTA Effective, Efficient in Ruling Out Patients With Suspected ACS Jason Kahn March 26, 2012
News Conference News ACC 2012 INFUSE-AMI: Bolus Abciximab Works, Thrombus Aspiration Doesn’t for Large STEMI Jason Kahn March 25, 2012
News Conference News ACC 2012 CPORT-E: PCI Outcomes Similar Regardless of On-Site Cardiac Surgery March 25, 2012
News Conference News ACC 2012 Color Coding, Checklists Improve Use of Evidence-Based Strategies for ACS L.A. McKeown March 25, 2012
News Conference News ACC 2012 BCIS-1: Long-Term Follow-up Shows Lower Mortality with Elective IABP Therapy Jason Kahn March 25, 2012
News Conference News ACC 2012 Three Months of Antiplatelet Therapy with Endeavor Equal to 1 Year with Other DES Jason Kahn March 24, 2012
News Conference News ACC 2012 Prasugrel Effective in Stable Patients With Poor Response to Clopidogrel Jason Kahn March 24, 2012
News Conference News ACC 2012 New Antiplatelet Agent Vorapaxar Shows Promise, But At the Expense of Bleeding L.A. McKeown March 24, 2012